Signify Premium Insight: Exo Secures $220m in Series C Funding

The handheld ultrasound market continues to garner investor interest, with Exo the latest company to benefit from a weighty funding round. The California-based start-up has announced it has raised $220m in a Series C investment round. The vendor says it is set to use the money to fund the commercialisation of its PMUT transducer,  dubbed Cello. Exo also has a handheld ultrasound scanner currently awaiting FDA approval, as well as its complementary point of care ultrasound workflow solution, Exo Works, in order to create an entire imaging workflow.